Literature DB >> 4793883

In vitro effect of virazole against influenza viruses.

Y Togo.   

Abstract

The minimal inhibitory concentrations of Virazole against 32 mean tissue culture infective doses of three type A influenza strains including type A/England/42/72 (H3N2) and a type B strain in tissue culture were 0.1 and 0.05 mug/ml, respectively. The growth inhibition pattern by various Virazole concentrations of type A virus was similar to that of the type B virus. Virazole appears to be slightly more potent against the A/England/42/72 strain than are other antiinfluenzal agents.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4793883      PMCID: PMC444610          DOI: 10.1128/AAC.4.6.641

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride.

Authors:  G C Schild; R N Sutton
Journal:  Br J Exp Pathol       Date:  1965-06

2.  Antiviral activity of cyclooctylamine hydrochloride in cell culture and mouse systems.

Authors:  W B Flagg; F J Stanfield; R F Haff; R C Stewart; R J Stedman; J Gold; R J Ferlauto
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

3.  Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.

Authors:  R W Sidwell; J H Huffman; G P Khare; L B Allen; J T Witkowski; R K Robins
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

4.  In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses.

Authors:  J H Huffman; R W Sidwell; G P Khare; J T Witkowski; L B Allen; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

  4 in total
  7 in total

1.  Efficacy of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide against influenza virus infections in mice.

Authors:  F E Durr; H F Lindh; M Forbes
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

Review 2.  Ribavirin: a clinical overview.

Authors:  H Fernandez; G Banks; R Smith
Journal:  Eur J Epidemiol       Date:  1986-03       Impact factor: 8.082

3.  Effects of small-particle aerosols of rimantadine and ribavirin on arterial blood pH and gas tensions and lung water content of A2 influenza-infected mice.

Authors:  J B Arensman; J W Dominik; D E Hilmas
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

Review 4.  Ribavirin and inosiplex: a review of their present status in viral diseases.

Authors:  T W Chang; R C Heel
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

5.  Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance.

Authors:  M J Browne; M Y Moss; M R Boyd
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

6.  Comparative inhibition of influenza and parainfluenza virus replication by ribavirin in MDCK cells.

Authors:  M J Browne
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

7.  Plaque inhibition assay for drug susceptibility testing of influenza viruses.

Authors:  F G Hayden; K M Cote; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.